Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 11Leukemia, Myelomonocytic, Acute 10Leukemia, Monocytic, Acute 10Leukemia, Megakaryoblastic, Acute 10Leukemia, Erythroblastic, Acute 10Congenital Abnormalities 8Breast Neoplasms 8Anemia, Refractory, with Excess of Blasts 5Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Eosinophilic, Acute 4Leukemia, Basophilic, Acute 4Leukemia 4Gliosarcoma 4Glioblastoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Melanoma 3Medulloblastoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Inflammatory Breast Neoplasms 3Breast Neoplasms, Male 3Blast Crisis 3Wilms Tumor 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Thrombocythemia, Essential 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2

Interventions

Sunitinib 2MK 2206 2Hu-Mik-beta-1 monoclonal antibody 2Cyclosporine 2Carboplatin 2tipifarnib 1sargramostim 1nelarabine 1cediranib 1Vorinostat 1Therapeutics 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Microarray Analysis 1MLN 8237 1Levofloxacin 1Lenalidomide 1Ketamine 1Interleukin-12 Subunit p35 1Interferon-alpha 1Imatinib Mesylate 1Ifosfamide 1Gene Expression Profiling 1Etoposide 1Docetaxel 1Dexamethasone 1Decitabine 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Large Granular Lymphocytic × tipifarnib × Clear all
NCT00360776 2017-04-05

Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
25 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡